Victrix leverages over 20 years of pharmaceutical and biotechnology experience to provide computational and business development solutions for every budget.
|
|
Our clients include:
We offer the following services:
|
What People are saying about Victrix:
Miguel Garcia-Guzman, Co-founder, Head R&D, Biology at CendR Inc., Greater San Diego Area
I have worked with Adam during my tenure at Vertex Pharmaceuticals and now at Aspyrian Therapeutics. Adam is an extraordinary computational scientist with the unique ability to combine extensive knowledge of biology, pharmacology and chemical concepts to his modeling efforts. He is a great person, a great collaborator, and a great scientist, and I highly recommend him for anyone in need of computational chemistry support.
Roger Heim, Research Scientist at Aspyrian Therapeutics Inc., Greater San Diego Area
At Aspyrian Therapeutics we have contracted with Adam Kallel from Victrix for a new drug discovery target. Using his own software, Adam built a 3D-homology model for our target, based on a the crystal structure of a related protein. Adam validated the model with established and novel molecules that all docked well, and he ran a virtual screen of 1.9 million compounds. Adam readily delivered a prioritized hit list and gave the project new impulses with additional suggestions.
Jim Wikel, Chief Chemistry Officer at Apex Therapeutics Inc and Scientific Advisor at Collaborative Drug Discovery, Inc.
Victrix was an active participant in a project for which I was a consultant. I was impressed with Victrix's ability to take barely the seed of a project proposal, and distill it into an action step. Victrix formulated the project idea into a workable in silico screening strategy and completed the task in a timely and efficient manner. The reduction of the idea to practice was exactly what his client was seeking. In addition, Victrix made the contacts to supply the material for biological testing.
I have worked with Adam during my tenure at Vertex Pharmaceuticals and now at Aspyrian Therapeutics. Adam is an extraordinary computational scientist with the unique ability to combine extensive knowledge of biology, pharmacology and chemical concepts to his modeling efforts. He is a great person, a great collaborator, and a great scientist, and I highly recommend him for anyone in need of computational chemistry support.
Roger Heim, Research Scientist at Aspyrian Therapeutics Inc., Greater San Diego Area
At Aspyrian Therapeutics we have contracted with Adam Kallel from Victrix for a new drug discovery target. Using his own software, Adam built a 3D-homology model for our target, based on a the crystal structure of a related protein. Adam validated the model with established and novel molecules that all docked well, and he ran a virtual screen of 1.9 million compounds. Adam readily delivered a prioritized hit list and gave the project new impulses with additional suggestions.
Jim Wikel, Chief Chemistry Officer at Apex Therapeutics Inc and Scientific Advisor at Collaborative Drug Discovery, Inc.
Victrix was an active participant in a project for which I was a consultant. I was impressed with Victrix's ability to take barely the seed of a project proposal, and distill it into an action step. Victrix formulated the project idea into a workable in silico screening strategy and completed the task in a timely and efficient manner. The reduction of the idea to practice was exactly what his client was seeking. In addition, Victrix made the contacts to supply the material for biological testing.
